|
GB9801392D0
(en)
*
|
1998-01-22 |
1998-03-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9803411D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6194410B1
(en)
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
CA2338994A1
(en)
*
|
1998-07-31 |
2000-02-10 |
Paul Leslie Ornstein |
Sulfonamide derivatives
|
|
GB9818914D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
PE20020063A1
(es)
|
2000-06-20 |
2002-01-30 |
Upjohn Co |
Bis-arilsulfonas como ligandos del receptor de 5-ht
|
|
US6586592B2
(en)
|
2000-06-20 |
2003-07-01 |
Pharmacia & Upjohn Company |
Bis-arylsulfones
|
|
SE0002739D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New use
|
|
US6399617B1
(en)
*
|
2000-07-21 |
2002-06-04 |
Biovitrum Ab |
Use
|
|
GB0021450D0
(en)
*
|
2000-08-31 |
2000-10-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
US7034029B2
(en)
|
2000-11-02 |
2006-04-25 |
Wyeth |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
WO2002042293A1
(en)
*
|
2000-11-21 |
2002-05-30 |
Smithkline Beecham P.L.C. |
Isoquinoline derivatives useful in the treatment of cns disorders
|
|
CN1329382C
(zh)
|
2001-05-11 |
2007-08-01 |
比奥维特罗姆股份公司 |
治疗肥胖、ⅱ型糖尿病和cns－疾病的芳基磺酰胺化合物
|
|
US7718650B2
(en)
|
2001-05-11 |
2010-05-18 |
Biovitrum Ab |
Aryl sulfonamide compounds for treating obesity
|
|
KR100889718B1
(ko)
*
|
2001-06-11 |
2009-03-23 |
바이오비트럼 에이비(피유비엘) |
치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형당뇨병 치료용 약제로서의 이들의 사용 방법
|
|
CA2456250A1
(en)
*
|
2001-08-10 |
2003-02-20 |
F. Hoffmann-La Roche Ag |
Arylsulfonyl derivatives with 5-ht6 receptor affinity
|
|
EP1461325B1
(en)
*
|
2001-11-22 |
2010-05-26 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
AU2007205749B2
(en)
*
|
2001-11-22 |
2009-04-23 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
EA200400707A1
(ru)
|
2001-11-22 |
2004-10-28 |
Биовитрум Аб |
Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
|
|
IL160630A0
(en)
*
|
2001-11-22 |
2004-07-25 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
EA200400708A1
(ru)
|
2001-11-22 |
2004-10-28 |
Биовитрум Аб |
Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
|
|
US20050085461A1
(en)
*
|
2002-02-13 |
2005-04-21 |
Cooper David G. |
Benzenesulfonamide derivatives
|
|
AU2003215558A1
(en)
*
|
2002-02-13 |
2003-09-04 |
Glaxo Group Limited |
Benzenesulfonamide derivatives as antipsychotic agents
|
|
EP1487801B1
(en)
*
|
2002-02-13 |
2006-04-19 |
Glaxo Group Limited |
7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
|
|
GB0204720D0
(en)
*
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Novel use
|
|
SI1497266T1
(sl)
*
|
2002-03-27 |
2008-10-31 |
Glaxo Group Ltd |
Derivati kinolina in njihova uporaba kot ligandi 5-ht6
|
|
DE60303376T2
(de)
|
2002-05-13 |
2006-11-16 |
F. Hoffmann-La Roche Ag |
Benzoxazinderivate als 5-ht6-modulatoren und deren verwendungen
|
|
EP2399903A1
(en)
|
2002-05-24 |
2011-12-28 |
Millennium Pharmaceuticals, Inc. |
Ccr9 inhibitors and methods of use thereof
|
|
JP4754821B2
(ja)
|
2002-06-20 |
2011-08-24 |
プロキシマゲン・リミテッド |
肥満症、ｉｉ型糖尿病およびｃｎｓ障害の治療に有用な新規化合物
|
|
EP1897876A3
(en)
|
2002-06-20 |
2009-03-18 |
Biovitrum AB (publ) |
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
|
DE60309498T2
(de)
|
2002-10-18 |
2007-08-30 |
F. Hoffmann-La Roche Ag |
4-piperazinylbenzolsulfonyl-indole mit 5-ht6 rezeptor-affinität
|
|
AU2003298661B2
(en)
|
2002-11-18 |
2007-05-10 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7227035B2
(en)
*
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
US20070021466A1
(en)
*
|
2002-11-18 |
2007-01-25 |
Solomon Ungashe |
CCR2 inhibitors and methods of use thereof
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7741519B2
(en)
|
2007-04-23 |
2010-06-22 |
Chemocentryx, Inc. |
Bis-aryl sulfonamides
|
|
RU2327689C2
(ru)
*
|
2003-03-03 |
2008-06-27 |
Ф.Хоффманн-Ля Рош Аг |
2,5- замещенные тетрагидроизохинолины и фармацевтическая композиция для модуляции 5-нт6
|
|
TWI289141B
(en)
|
2003-03-11 |
2007-11-01 |
Hoffmann La Roche F. Ag. |
Quinolinone derivatives and uses thereof
|
|
GB0305575D0
(en)
*
|
2003-03-11 |
2003-04-16 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1558582B1
(en)
|
2003-07-22 |
2005-12-21 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
US20050201965A1
(en)
*
|
2004-03-11 |
2005-09-15 |
The Procter & Gamble Company |
Personal cleansing compositions
|
|
CA2566387A1
(en)
*
|
2004-05-12 |
2005-12-01 |
Chemocentryx, Inc. |
Aryl sulfonamides as chemokine receptor ccr9 antagonists
|
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
ES2348467T3
(es)
|
2004-09-30 |
2010-12-07 |
F. Hoffmann-La Roche Ag |
Derivados y usos de la benzoxazina y la quinoxalina.
|
|
EP1695971A1
(en)
*
|
2004-12-30 |
2006-08-30 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted phenyl-piperazine compounds, their preparation and use in medicaments
|
|
AR054044A1
(es)
*
|
2005-05-23 |
2007-05-30 |
Astrazeneca Ab |
Derivados de cromano y tetrahidronaftaleno como moduladores del receptor 5 - ht6; intermediarios en su preparacion; composiciones farmaceuticas que los contienen y su empelo en la fabricacion de medicamentos para el tratamiento de enfermedades del snc y de la obesidad.
|
|
AR054363A1
(es)
*
|
2005-05-23 |
2007-06-20 |
Astrazeneca Ab |
Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
|
|
PT1919896E
(pt)
*
|
2005-08-12 |
2010-02-26 |
Suven Life Sciences Ltd |
Derivados de aminoaril sulfonamida como ligandos funcionais de 5-ht6
|
|
WO2007020654A1
(en)
|
2005-08-16 |
2007-02-22 |
Suven Life Sciences |
An improved process for the preparation of losartan
|
|
NZ593074A
(en)
*
|
2005-12-21 |
2012-04-27 |
Vertex Pharma |
sulfonamide-pyrrolidone derivatives as Modulators of Ion Channels
|
|
WO2007133580A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Zelos Therapeutics, Inc. |
Use of pth (1-31) and optionally g-csf for hematopoietic stimulation
|
|
MX2009006077A
(es)
|
2007-01-08 |
2009-06-17 |
Suven Life Sciences Ltd |
Compuestos de 5-(heterociclil)alquil-n-(arilsulfonil)indol y su uso como ligandos de la 5-hidroxitriptamina6.
|
|
WO2008113818A1
(en)
*
|
2007-03-21 |
2008-09-25 |
Glaxo Group Limited |
Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
|
|
US8263588B2
(en)
|
2007-04-06 |
2012-09-11 |
Neurocrine Biosciences, Inc. |
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
|
|
NZ580457A
(en)
|
2007-04-06 |
2012-03-30 |
Neurocrine Biosciences Inc |
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
|
|
KR101162482B1
(ko)
|
2007-05-03 |
2012-07-03 |
수벤 라이프 사이언시스 리미티드 |
아미노알콕시 아릴술폰아미드 화합물 및 ５-ｈｔ６ 리간드로서의 그의 용도
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
DK2200980T3
(da)
|
2007-10-26 |
2011-11-21 |
Suven Life Sciences Ltd |
Aminoarylsulfonamidforbindelser og deres anvendelse som 5-HT6-ligander
|
|
EP2254564A1
(en)
|
2007-12-12 |
2010-12-01 |
Glaxo Group Limited |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
|
|
EP2103596A1
(en)
|
2008-03-18 |
2009-09-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Process for the preparation of N-(phenylethyl) anilines salts and solvates thereof useful as serotonin 5-HT6 antagonists
|
|
US20110021538A1
(en)
|
2008-04-02 |
2011-01-27 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
US20110034565A1
(en)
|
2008-04-18 |
2011-02-10 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
DE102008022221A1
(de)
|
2008-05-06 |
2009-11-12 |
Universität des Saarlandes |
Inhibitoren der humanen Aldosteronsynthase CYP11B2
|
|
US8318725B2
(en)
|
2008-09-17 |
2012-11-27 |
Suven Life Sciences Limited |
Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
|
|
HRP20130721T1
(en)
*
|
2008-09-17 |
2013-09-30 |
Suven Life Sciences Limited |
Aryl sulfonamide amine compounds and their use as 5-ht6 ligands
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
UA100192C2
(en)
*
|
2008-11-11 |
2012-11-26 |
УАЙТ ЭлЭлСи |
1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
|
|
US8183237B2
(en)
|
2009-04-30 |
2012-05-22 |
Abbott Laboratories |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
US8343959B2
(en)
|
2009-04-30 |
2013-01-01 |
Abbott Gmbh & Co. Kg |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
JP2012525356A
(ja)
|
2009-04-30 |
2012-10-22 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
セロトニン５−ｈｔ６受容体の調節に応答する障害を治療するのに適したベンゼンスルホンアニリド化合物
|
|
UA107080C2
(uk)
*
|
2009-04-30 |
2014-11-25 |
|
Сполуки n-феніл(піперазиніл або гомопіперазиніл)бензолсульфонаміду або бензолсульфонілфеніл(піперазину або гомопіперазину), придатні для лікування захворювань, які реагують на модулювання рецептора 5-ht6 серотоніну
|
|
ES2547072T3
(es)
*
|
2009-07-21 |
2015-10-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Heteroaril benzamidas, composiciones y métodos de utilización
|
|
US8541404B2
(en)
|
2009-11-09 |
2013-09-24 |
Elexopharm Gmbh |
Inhibitors of the human aldosterone synthase CYP11B2
|
|
AU2010340745B2
(en)
|
2010-01-05 |
2014-11-20 |
Suven Life Sciences Limited |
Sulfone compounds as 5-HT6 receptor ligands
|
|
GB201002563D0
(en)
|
2010-02-15 |
2010-03-31 |
Cambridge Entpr Ltd |
Compounds
|
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
|
WO2012059432A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
|
WO2013055793A1
(en)
|
2011-10-12 |
2013-04-18 |
University Of Pittsburg-Of The Commonwealth System Of Higher Education |
Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer
|
|
CN104379559B
(zh)
*
|
2012-04-27 |
2016-11-09 |
葛兰素集团有限公司 |
化合物
|
|
EP3046561B1
(en)
|
2013-09-20 |
2023-02-22 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Compounds for treating prostate cancer
|
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
CN104557664B
(zh)
*
|
2013-10-19 |
2020-01-21 |
广东东阳光药业有限公司 |
芳杂环类衍生物及其在药物上的应用
|
|
CA2928537A1
(en)
*
|
2013-10-25 |
2015-04-30 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2015090233A1
(en)
|
2013-12-20 |
2015-06-25 |
Sunshine Lake Pharma Co., Ltd. |
Aromatic heterocyclic compounds and their application in pharmaceuticals
|
|
CN105085436B
(zh)
*
|
2014-04-19 |
2019-08-16 |
广东东阳光药业有限公司 |
磺酰胺类衍生物及其在药物上的应用
|
|
CN105367474A
(zh)
*
|
2014-08-12 |
2016-03-02 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
CN104529866A
(zh)
*
|
2014-12-12 |
2015-04-22 |
广东东阳光药业有限公司 |
吲哚类衍生物及其在药物上的应用
|
|
CN104496987B
(zh)
*
|
2014-12-12 |
2016-03-02 |
广东东阳光药业有限公司 |
取代杂环类化合物及其在药物上的应用
|
|
HK1245660A1
(zh)
|
2015-06-12 |
2018-08-31 |
Axovant Sciences Gmbh |
有用於预防和治疗rem睡眠行为障碍的二芳基脲和芳基脲衍生物
|
|
WO2017011767A2
(en)
|
2015-07-15 |
2017-01-19 |
Axovant Sciences Ltd. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
|
|
HK1257102A1
(zh)
|
2015-08-21 |
2019-10-11 |
Portola Pharmaceuticals, Inc. |
苯基哌嗪前蛋白转化酶枯草杆菌蛋白酶/kexin9型(pcsk9)调节剂及其应用
|
|
WO2017034990A1
(en)
|
2015-08-21 |
2017-03-02 |
Portola Pharmaceuticals, Inc. |
Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate pcsk9 protein activity
|
|
EP3337497B1
(en)
|
2015-08-21 |
2023-07-12 |
SRX Cardio, LLC |
Composition and methods of use of novel phenylalanine small organic compounds to directly modulate pcsk9 protein activity
|
|
US20190119236A1
(en)
|
2016-02-23 |
2019-04-25 |
Portola Pharmaceuticals, Inc. |
Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
|
|
US10980806B2
(en)
|
2016-03-24 |
2021-04-20 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
CN111517963A
(zh)
*
|
2020-06-02 |
2020-08-11 |
杭州福莱蒽特科技有限公司 |
环保型2，6-二氯-4-硝基苯胺的制备方法
|
|
US12115154B2
(en)
|
2020-12-16 |
2024-10-15 |
Srx Cardio, Llc |
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
|